SEARCH

SEARCH BY CITATION

References

  • 1
    Mechoulam R (1986) The Pharmaco History of Cannabis sativa. CRC Press, Boca Raton, FL.
  • 2
    Mackie K (2006) Cannabinoid receptors as therapeutic targets. Annu Rev Pharmacol Toxicol 46, 101122.
  • 3
    Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A & Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 19461949.
  • 4
    Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR & Compton DR (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50, 8390.
  • 5
    Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A & Waku K (1995) 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 215, 8997.
  • 6
    Hanus L, Abu-Lafi S, Fride E, Breuer A, Vogel Z, Shalev DE, Kustanovich I & Mechoulam R (2001) 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor. Proc Natl Acad Sci USA 98, 36623665.
  • 7
    Porter AC, Sauer JM, Knierman MD, Becker GW, Berna MJ, Bao J, Nomikos GG, Carter P, Bymaster FP, Leese AB, et al. (2002) Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. J Pharmacol Exp Ther 301, 10201024.
  • 8
    Huang SM, Bisogno T, Trevisani M, Al-Hayani A, De Petrocellis L, Fezza F, Tognetto M, Petros TJ, Krey JF, Chu CJ, et al. (2002) An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc Natl Acad Sci USA 99, 84008405.
  • 9
    Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, et al. (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54, 161202.
  • 10
    Ledent C, Valverde O, Cossu G, Petitet F, Aubert JF, Bohme GA, Imperato A, Pedrazzini T, Roques BP, Vassart G, et al. (1999) Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283, 401404.
  • 11
    Zimmer A, Zimmer AM, Hohmann AG, Herkenham M & Bonner TI (1999) Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc Natl Acad Sci USA 96, 57805785.
  • 12
    Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR & Rice KC (1990) Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 87, 19321936.
  • 13
    Tsou K, Brown S, Sanudo-Pena MC, Mackie K & Walker JM (1998) Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83, 393411.
  • 14
    Schlicker E & Kathmann M (2001) Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol Sci 22, 565572.
  • 15
    Wilson RI & Nicoll RA (2002) Endocannabinoid signaling in the brain. Science 296, 678682.
  • 16
    Matias I & Di Marzo V (2007) Endocannabinoids and the control of energy balance. Trends Endocrinol Metab 18, 2737.
  • 17
    Lunn CA, Reich EP & Bober L (2006) Targeting the CB2 receptor for immune modulation. Expert Opin Ther Targets 10, 653663.
  • 18
    Van Sickle MD, Duncan M, Kingsley PJ, Mouihate A, Urbani P, Mackie K, Stella N, Makriyannis A, Piomelli D, Davison JS, et al. (2005) Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 310, 329332.
  • 19
    Gong JP, Onaivi ES, Ishiguro H, Liu QR, Tagliaferro PA, Brusco A, Akinshola BE, Liu QR, Hope B, Iwasaki S, et al. (2006) Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res 1071, 1023.
  • 20
    Onaivi ES, Ishiguro H, Gong JP, Patel S, Perchuk A, Meozzi PA, Myers L, Mora Z, Tagliaferro P, Gardner E, et al. (2006) Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Ann N Y Acad Sci 1074, 514536.
  • 21
    Viscomi MT, Oddi S, Latini L, Pasquariello N, Florenzano F, Bernardi G, Molinari M & Maccarrone M (2009) Selective CB2 receptor agonism protects central neurons from remote axotomy-induced apoptosis through the PI3K/Akt pathway. J Neurosci 29, 45644570.
  • 22
    Ryberg E, Larsson N, Sjögren S, Hjorth S, Hermansson NO, Leonova J, Elebring T, Nilsson K, Drmota T & Greasley PJ (2007) The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol 152, 10921101.
  • 23
    Oka S, Nakajima K, Yamashita A, Kishimoto S & Sugiura T (2007) Identification of GPR55 as a lysophosphatidylinositol receptor. Biochem Biophys Res Commun 362, 928934.
  • 24
    Ross RA (2009) The enigmatic pharmacology of GPR55. Trends Pharmacol Sci 30, 156163.
  • 25
    Moriconi A, Cerbara I, Maccarrone M & Topai A (2010) GPR55: current knowledge and future perspectives of a purported ‘type-3′ cannabinoid receptor. Curr Med Chem 17, 14111429.
  • 26
    Oz M (2006) Receptor-independent effects of endocannabinoids on ion channels. Curr Pharm Des 12, 227239.
  • 27
    De Petrocellis L & Di Marzo V (2010) Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels. J Neuroimmune Pharmacol 5, 103121.
  • 28
    O'Sullivan SE (2007) Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors. Br J Pharmacol 152, 576582.
  • 29
    Pistis M & Melis M (2010) From surface to nuclear receptors: the endocannabinoid family extends its assets. Curr Med Chem 17, 14501467.
  • 30
    Di Marzo V, Bisogno T & De Petrocellis L (2007) Endocannabinoids and related compounds: walking back and forth between plant natural products and animal physiology. Chem Biol 14, 741756.
  • 31
    Ueda N, Tsuboi K & Uyama T (2013) Metabolism of endocannabinoids and related N-acylethanolamines: canonical and alternate pathways. FEBS J 280, 18741894.
  • 32
    De Petrocellis L & Di Marzo V (2009) An introduction to the endocannabinoid system: from the early to the latest concepts. Best Pract Res Clin Endocrinol Metab 23, 115.
  • 33
    Okamoto Y, Morishita J, Tsuboi K, Tonai T & Ueda N (2004) Molecular characterization of a phospholipase D generating anandamide and its congeners. J Biol Chem 279, 52985305.
  • 34
    Bisogno T, Howell F, Williams G, Minassi A, Cascio MG, Ligresti A, Matias I, Schiano-Moriello A, Paul P, Williams EJ, et al. (2003) Cloning of the first sn-1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. Cell Biol 163, 463468.
  • 35
    Ueda N, Tsuboi K & Uyama T (2010) N-acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA). Prog Lipid Res 49, 299315.
  • 36
    McKinney MK & Cravatt BF (2005) Structure and function of fatty acid amide hydrolase. Annu Rev Biochem 74, 411432.
  • 37
    Fezza F, De Simone C, Amadio D & Maccarrone M (2008) Fatty acid amide hydrolase: a gate-keeper of the endocannabinoid system. Subcell Biochem 49, 101132.
  • 38
    Dinh TP, Freund TF & Piomelli D (2002) A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation. Chem Phys Lipids 121, 149158.
  • 39
    Wei BQ, Mikkelsen TS, McKinney MK, Lander ES & Cravatt BF (2006) A second fatty acid amide hydrolase with variable distribution among placental mammals. J Biol Chem 281, 3656936578.
  • 40
    Tsuboi K, Sun YX, Okamoto Y, Araki N, Tonai T & Ueda N (2005) Molecular characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase. J Biol Chem 280, 1108211092.
  • 41
    Rouzer CA & Marnett LJ (2011) Endocannabinoid oxygenation by cyclooxygenases, lipoxygenases, and cytochromes P450: cross-talk between the eicosanoid and endocannabinoid signaling pathways. Chem Rev 111, 58995921.
  • 42
    van der Stelt M, van Kuik JA, Bari M, van Zadelhoff G, Leeflang BR, Veldink GA, Finazzi-Agrò A, Vliegenthart JF & Maccarrone M (2002) Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase. J Med Chem 45, 37093720.
  • 43
    Rouzer CA & Marnett LJ (2008) Non-redundant functions of cyclooxygenases: oxygenation of endocannabinoids. J Biol Chem 283, 80658069.
  • 44
    Woodward DF, Liang Y & Krauss AH (2008) Prostamides (prostaglandin-ethanolamides) and their pharmacology. Br J Pharmacol 153, 410419.
  • 45
    Fowler CJ (2013) Transport of endocannabinoids across the plasma membrane and within the cell. FEBS J 280, in press.
  • 46
    Chicca A, Marazzi J, Nicolussi S & Gertsch J (2012) Evidence for bidirectional endocannabinoid transport across cell membranes. J Biol Chem 287, 3466034682.
  • 47
    Fu J, Bottegoni G, Sasso O, Bertorelli R, Rocchia W, Masetti M, Guijarro A, Lodola A, Armirotti A, Garau G, et al. (2011) A catalytically silent FAAH-1 variant drives anandamide transport in neurons. Nat Neurosci 15, 6469.
  • 48
    Kaczocha M, Glaser ST & Deutsch DG (2009) Identification of intracellular carriers for the endocannabinoid anandamide. Proc Natl Acad Sci USA 106, 63756380.
  • 49
    Oddi S, Fezza F, Pasquariello N, D'Agostino A, Catanzaro G, De Simone C, Rapino C, Finazzi-Agrò A & Maccarrone M (2009) Molecular identification of albumin and Hsp70 as cytosolic anandamide-binding proteins. Chem Biol 16, 624632.
  • 50
    Maccarrone M, Dainese E & Oddi S (2010) Intracellular trafficking of anandamide: new concepts for signaling. Trends Biochem Sci 35, 601608.
  • 51
    Waddington CH (1942) The epigenotype. Endeavour 1, 1820.
  • 52
    Riddihough G & Zahn LM (2010) Epigenetics. What is epigenetics? Introduction. Science 330, 611.
  • 53
    Bird A (2002) DNA methylation patterns and epigenetic memory. Genes Dev 16, 621.
  • 54
    Miranda TB & Jones PA (2007) DNA methylation: the nuts and bolts of repression. J Cell Physiol 213, 384390.
  • 55
    Deplus R, Brenner C, Burgers WA, Putmans P, Kouzarides T, de Launoit Y & Fuks F (2002) Dnmt3L is a transcriptional repressor that recruits histone deacetylase. Nucleic Acids Res 30, 38313838.
  • 56
    Esteller M (2008) Epigenetics in evolution and disease. Lancet 372, 9096.
  • 57
    Gardiner-Garden M & Frommer M (1987) CpG islands in vertebrate genomes. J Mol Biol 196, 261282.
  • 58
    Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, Cui H, Gabo K, Rongione M, Webster M, et al. (2009) The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 41, 178186.
  • 59
    Doi A, Park IH, Wen B, Murakami P, Aryee MJ, Irizarry R, Herb B, Ladd-Acosta C, Rho J, Loewer S, et al. (2009) Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet 41, 13501353.
  • 60
    Luger K, Rechsteiner TJ & Richmond TJ (1999) Preparation of nucleosome core particle from recombinant histones. Methods Enzymol 304, 319.
  • 61
    Turner BM (2002) Cellular memory and the histone code. Cell 111, 285291.
  • 62
    Bernstein BE, Meissner A & Lander ES (2007) The mammalian epigenome. Cell 128, 669681.
  • 63
    Borrelli E, Nestler EJ, Allis CD & Sassone-Corsi P (2008) Decoding the epigenetic language of neuronal plasticity. Neuron 60, 961974.
  • 64
    Kouzarides T (2007) Chromatin modifications and their function. Cell 128, 693705.
  • 65
    Lee BM & Mahadevan LC (2009) Stability of histone modifications across mammalian genomes: implications for ‘epigenetic’ marking. J Cell Biochem 108, 2234.
  • 66
    Strahl BD & Allis CD (2000) The language of covalent histone modifications. Nature 403, 4145.
  • 67
    de Ruijter AJ, van Gennip AH, Caron HN, Kemp S & van Kuilenburg AB (2003) Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 370, 737749.
  • 68
    Martin C & Zhang Y (2005) The diverse functions of histone lysine methylation. Nat Rev 6, 838849.
  • 69
    Sims RJ III, Nishioka K & Reinberg D (2003) Histone lysine methylation: a signature for chromatin function. Trends Genet 19, 629639.
  • 70
    Tamaru H & Selker EU (2001) A histone H3 methyltransferase controls DNA methylation in Neurospora crassa. Nature 414, 277283.
  • 71
    Henckel A, Nakabayashi K, Sanz LA, Feil R, Hata K & Arnaud P (2009) Histone methylation is mechanistically linked to DNA methylation at imprinting control regions in mammals. Hum Mol Genet 18, 33753383.
  • 72
    Yuan GC, Liu YJ, Dion MF, Slack MD, Wu LF, Altschuler SJ & Rando OJ (2005) Genome-scale identification of nucleosome positions in S. cerevisiae. Science 309, 626630.
  • 73
    Chodavarapu RK, Feng S, Bernatavichute YV, Chen PY, Stroud H, Yu Y, Hetzel JA, Kuo F, Kim J, Cokus SJ, et al. (2010) Relationship between nucleosome positioning and DNA methylation. Nature 466, 388392.
  • 74
    Guil S & Esteller M (2009) DNA methylomes, histone codes and miRNAs: tying it all together. Int J Biochem Cell Biol 41, 8795.
  • 75
    Shenouda SK & Alahari SK (2009) MicroRNA function in cancer: oncogene or a tumor suppressor? Cancer Metastasis Rev 28, 369378.
  • 76
    Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281297.
  • 77
    Lachmann A, Xu H, Krishnan J, Berger SI, Mazloom AR & Ma'ayan A (2010) ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments. Bioinformatics 26, 24382444.
  • 78
    Laprairie RB, Kelly ME & Denovan-Wright EM (2012) The dynamic nature of type 1 cannabinoid receptor (CB (1)) gene transcription. Br J Pharmacol 167, 15831590.
  • 79
    Wang D, Wang H, Ning W, Backlund MG, Dey SK & DuBois RN (2008) Loss of cannabinoid receptor 1 accelerates intestinal tumor growth. Cancer Res 68, 64686476.
  • 80
    Massa F, Marsicano G, Hermann H, Cannich A, Monory K, Cravatt BF, Ferri GL, Sibaev A, Storr M & Lutz B (2004) The endogenous cannabinoid system protects against colonic inflammation. J Clin Invest 113, 12021209.
  • 81
    Xia D, Wang D, Kim SH, Katoh H & DuBois RN (2012) Prostaglandin E2 promotes intestinal tumor growth via DNA methylation. Nat Med 18, 224226.
  • 82
    Franklin TB, Russig H, Weiss IC, Gräff J, Linder N, Michalon A, Vizi S & Mansuy IM (2010) Epigenetic transmission of the impact of early stress across generations. Biol Psychiatry 68, 408415.
  • 83
    Viveros MP, Marco EM, Llorente R & López-Gallardo M (2007) Endocannabinoid system and synaptic plasticity: implications for emotional responses. Neural Plast 2007, 52908.
  • 84
    Börner C, Martella E, Höllt V & Kraus J (2012) Regulation of opioid and cannabinoid receptor genes in human neuroblastoma and T cells by the epigenetic modifiers trichostatin A and 5-aza-2′-deoxycytidine. NeuroImmunoModulation 19, 180186.
  • 85
    Kraus J, Lehmann L, Börner C & Hollt V (2010) Epigenetic mechanisms involved in the induction of the mu opioid receptor gene in Jurkat T cells in response to interleukin-4. Mol Immunol 48, 257263.
  • 86
    Börner C, Hollt V, Sebald W & Kraus J (2007) Transcriptional regulation of the cannabinoid receptor type 1 gene in T cells by cannabinoids. J Leukoc Biol 81, 336343.
  • 87
    Centonze D, Rossi S, Finazzi-Agrò A, Bernardi G & Maccarrone M (2007) The (endo)cannabinoid system in multiple sclerosis and amyotrophic lateral sclerosis. Int Rev Neurobiol 82, 171186.
  • 88
    Frieling H, Albrecht H, Jedtberg S, Gozner A, Lenz B, Wilhelm J, Hillemacher T, de Zwaan M, Kornhuber J & Bleich S (2009) Elevated cannabinoid 1 receptor mRNA is linked to eating disorder related behavior and attitudes in females with eating disorders. Psychoneuroendocrinology 34, 620624.
  • 89
    Rotter A, Bayerlein K, Hansbauer M, Weiland J, Sperling W, Kornhuber J & Biermann T (2012) CB1 and CB2 receptor expression and promoter methylation in patients with cannabis dependence. Eur Addict Res 19, 1320.
  • 90
    D'Addario C, Di Francesco A, Arosio B, Gussago C, Dell'osso B, Bari M, Galimberti D, Scarpini E, Altamura AC, Mari D, et al. (2012) Epigenetic regulation of fatty acid amide hydrolase in Alzheimer disease. PLoS ONE 7, e39186.
  • 91
    Grimaldi P, Pucci M, Di Siena S, Di Giacomo D, Pirazzi V, Geremia R & Maccarrone M (2012) The faah gene is the first direct target of estrogen in the testis: role of histone demethylase LSD1. Cell Mol Life Sci 69, 41774190.
  • 92
    Orth JM, Gunsalus GL & Lamperti AA (1988) Evidence from Sertoli cell-depleted rats indicates that spermatid number in adults depends on numbers of Sertoli cells produced during perinatal development. Endocrinology 122, 787794.
  • 93
    Rossi G, Gasperi V, Paro R, Barsacchi D, Cecconi S & Maccarrone M (2007) Follicle-stimulating hormone activates fatty acid amide hydrolase by protein kinase A and aromatase-dependent pathways in mouse primary Sertoli cells. Endocrinology 148, 14311439.
  • 94
    Etcheverry A, Aubry M, de Tayrac M, Vauleon E, Boniface R, Guenot F, Saikali S, Hamlat A, Riffaud L, Menei P, et al. (2010) DNA methylation in glioblastoma: impact on gene expression and clinical outcome. BMC Genomics 11, 701.
  • 95
    Zimmerman S & Zimmerman AM (1990–1991) Genetic effects of marijuana. Int J Addict 25, 1933.
  • 96
    Stein GS & Stein JL (1984) Is human histone gene expression autogenously regulated? Mol Cell Biochem 64, 105110.
  • 97
    Fernández-Ruiz J, Gómez M, Hernández M, de Miguel R & Ramos JA (2004) Cannabinoids and gene expression during brain development. Neurotox Res 6, 389401.
  • 98
    Onaivi ES, Sugiura T & Di Marzo V (2006) Endocannabinoids: The Brain and Body's Marijuana and Beyond. CRC Press, Boca Raton, FL.
  • 99
    Tashkin DP, Cao W, Morganstern H, Greenland S, Roth MD, Simmons M & Zhang ZF (2004) Marijuana smoking and hypermethylation of the promoter region of the O6 (6)-methylguanine DNA methyltransferase gene (MGMT) DNA repair gene MGMT. ICRS Abstracts 73.
  • 100
    DiNieri JA, Wang X, Szutorisz H, Spano SM, Kaur J, Casaccia P, Dow-Edwards D & Hurd YL (2011) Maternal cannabis use alters ventral striatal dopamine D2 gene regulation in the offspring. Biol Psychiatry 70, 763769.
  • 101
    Tomasiewicz HC, Jacobs MM, Wilkinson MB, Wilson SP, Nestler EJ & Hurd YL (2012) Proenkephalin mediates the enduring effects of adolescent cannabis exposure associated with adult opiate vulnerability. Biol Psychiatry 72, 803810.
  • 102
    Akbarian S & Huang HS (2009) Epigenetic regulation in human brain-focus on histone lysine methylation. Biol Psychiatry 5, 198203.
  • 103
    Morris CV, DiNieri JA, Szutorisz H & Hurd YL (2011) Molecular mechanisms of maternal cannabis and cigarette use on human neurodevelopment. Eur J Neurosci 34, 15741583.
  • 104
    Aguado T, Carracedo A, Julien B, Velasco G, Milman G, Mechoulam R, Alvarez L, Guzmán M & Galve-Roperh I (2007) Cannabinoids induce glioma stem-like cell differentiation and inhibit gliomagenesis. J Biol Chem 282, 68546862.
  • 105
    Sadri-Vakili G, Bouzou B, Benn CL, Kim MO, Chawla P, Overland RP, Glajch KE, Xia E, Qiu Z, Hersch SM, et al. (2007) Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models. Hum Mol Genet 16, 12931306.
  • 106
    Eljaschewitsch E, Witting A, Mawrin C, Lee T, Schmidt PM, Wolf S, Hoertnagl H, Raine CS, Schneider-Stock R, Nitsch R, et al. (2006) The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells. Neuron 49, 6779.
  • 107
    Upham BL, Rummel AM, Carbone JM, Trosko JE, Ouyang Y, Crawford RB & Kaminski NE (2003) Cannabinoids inhibit gap junctional intercellular communication and activate ERK in a rat liver epithelial cell line. Int J Cancer 104, 1218.
  • 108
    Khare M, Taylor AH, Konje JC & Bell SC (2006) Delta9-tetrahydrocannabinol inhibits cytotrophoblast cell proliferation and modulates gene transcription. Mol Hum Reprod 12, 321333.
  • 109
    Chioccarelli T, Cacciola G, Altucci L, Lewis SE, Simon L, Ricci G, Ledent C, Meccariello R, Fasano S, Pierantoni R, et al. (2010) Cannabinoid receptor 1 influences chromatin remodeling in mouse spermatids by affecting content of transition protein 2 mRNA and histone displacement. Endocrinology 151, 50175029.
  • 110
    Paradisi A, Pasquariello N, Barcaroli D & Maccarrone M (2008) Anandamide regulates keratinocyte differentiation by inducing DNA methylation in a CB1 receptor-dependent manner. J Biol Chem 283, 60056012.
  • 111
    Molina PE, Amedee A, LeCapitaine NJ, Zabaleta J, Mohan M, Winsauer P & Vande Stouwe C (2011) Cannabinoid neuroimmune modulation of SIV disease. J Neuroimmune Pharmacol 6, 516527.
  • 112
    Surani MA (2001) Reprogramming of genome function through epigenetic inheritance. Nature 414, 122128.
  • 113
    Tsankova N, Renthal W, Kumar A & Nestler EJ (2007) Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci 8, 355367.
  • 114
    Levenson JM & Sweatt JD (2006) Epigenetic mechanisms: a common theme in vertebrate and invertebrate memory formation. Cell Mol Life Sci 63, 10091016.
  • 115
    Duman RS & Newton SS (2007) Epigenetic marking and neuronal plasticity. Biol Psychiatry 62, 13.
  • 116
    Esteller M (2007) Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 8, 286298.
  • 117
    Urdinguio RG, Sanchez-Mut JV & Esteller M (2009) Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies. Lancet Neurol 8, 10561072.
  • 118
    Pacher P & Kunos G (2013) Cannabinoids and endocannabinoids in human health/disease. FEBS J 280, in press.